Zangmeister Cancer Center Oncologist Dr. Taral Patel Presents Research at IASLC’s World Conference on Lung Cancer in Barcelona

/in /by

COLUMBUS, OHIO, Sept. 9, 2025 – American Oncology Network, one of the nation’s fastest-growing networks of community-based oncology practices, announced today that Board-certified medical oncologist Taral Patel, MD, of AON partner practice Zangmeister Cancer Center, authored and presented research at the IASLC 2025 World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer (#WCLC25) Sept. 6-9 in Barcelona, Spain.

Dr. Patel’s study, Assessment of molecular testing in stage IV non-small cell lung cancer patients across American Oncology Network, examined AON quality initiatives in collaboration with Integra Connect PrecisionQ to improve testing for stage IV patients. The abstract (Poster: P2.06.20) is available at cattendee.abstractsonline.com/meeting/21151/Session/180.

“Presenting our research at such a respected international conference was an incredible experience,” said Dr. Patel. “Having our work selected through a competitive process highlights its importance to the field. The opportunity to share findings with peers worldwide was both validating and inspiring, and it reinforced my commitment to advancing knowledge in lung cancer care.”

The IASLC World Conference on Lung Cancer is the largest global, multidisciplinary meeting focused solely on lung cancer and thoracic malignancies. Attendees include clinicians, researchers, allied health professionals, industry representatives, patients, survivors, caregivers and advocates.

“We are proud of Dr. Patel for presenting this important research on such a prominent stage,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Our physicians’ contributions to the scientific community are central to who we are as a network. Research and knowledge-sharing not only strengthen patient care within our practices but also advance the broader understanding of cancer treatment worldwide.”

Dr. Patel is a Board-certified medical oncologist and hematologist at Zangmeister Cancer Center, an AON partner practice. He is a diplomate of the American Board of Internal Medicine in medical oncology. He earned his M.B.B.S. from Baroda Medical College at the Maharaja Sayajirao University in Gujarat, India, where he also completed his internship and residency in pathology. He later served as a research associate at the University of Illinois at Chicago, completed his residency in internal medicine at Cook County Hospital in Chicago, and his fellowship in hematology/oncology at the University of Cincinnati. The author of numerous peer-reviewed publications, Dr. Patel is a member of the Community Oncology Alliance, Columbus Medical Association, Ohio State Medical Association, Ohio Hematology Oncology Society and the American Society of Clinical Oncology.

For more information about AON, visit AONcology.com. To learn more about Zangmeister Cancer Center, visit zangcenter.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Zangmeister Cancer Center
Designed for easy access and patient comfort, the Zangmeister Cancer Center offers a holistic array of cancer care services, including diagnostic imaging and chemotherapy treatment, laboratory services, genetic consultation, a specialty pharmacy, social support services, and access to cancer clinical trials. Zangmeister’s highly skilled and compassionate physicians use the latest advancements in the diagnosis, treatment, and prevention of cancer and blood disorders. Learn more at zangcenter.com.

About the International Association for the Study of Lung Cancer
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study and eradication of lung and other thoracic malignancies, founded in 1974. Its mission is to improve patient care through research, education, and collaboration among its more than 8,000 multidisciplinary members, including medical specialists, scientists, patients, and their caregivers. Key activities include hosting the annual World Conference on Lung Cancer (WCLC), publishing the Journal of Thoracic Oncology (JTO), and developing important guidelines for classification and diagnosis.

About Integra Connect
Integra Connect is a value-based precision medicine company, leading the industry in real-world data, analytics and AI capabilities for specialty care organizations. While other companies may focus on one of these areas, Integra Connect’s combined approach means providers, payers, and life sciences companies can see beyond their own experience to understand the full realities of cancer care and improve care, embrace scientific advancements, manage costs and deliver innovations that benefit patients. Integra Connect has the industry’s largest foothold into oncology practices focused on value-based care, with more than 5,000 providers supported by its solutions. As part of the Oncology Care Model, Integra Connect generates more than $260M in value-based care revenue and more than $100M in shared savings for participating practices. This experience led the organization to co-develop and administer one of the largest commercial oncology alternative payment models in the U.S.

Media Contact
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@aoncology.com

American Oncology Network and Low Country Cancer Care Welcome Dr. Anton Juncaj

/in /by

Medical oncologist joins Low Country Cancer Care’s physician team

SAVANNAH, Ga., Sept. 9, 2025 –  American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its partner practice, Low Country Cancer Care, are pleased to welcome medical oncologist Anton Juncaj, DO, to the physician care team. He will work alongside Dr. George Negrea, Jennifer Yannucci, Haven Caldwell, and Stephen Tiley.

Dr. Juncaj earned his Doctor of Osteopathic Medicine from the Alabama College of Osteopathic Medicine and a Master of Arts in medical sciences from Boston University School of Medicine Graduate Medical Sciences. He completed his residency in internal medicine and fellowship training in oncology and hematology at Ascension Genesys Hospital in Grand Blanc, Michigan. He has experience treating a wide range of solid tumors, hematologic malignancies, and benign hematologic conditions.

“I am honored to join the physician team at Low Country Cancer Care,” said Dr. Juncaj. “The practice has built a strong reputation for innovative, patient-centered care, and its commitment to excellence closely aligns with my own approach to medicine. I look forward to caring for LCCC patients.”

The Low Country Cancer Care team now includes five medical oncologists providing high quality care with state-of-the-art technology and the latest advances in clinical research and therapies across five locations in Georgia and South Carolina. The practice is dedicated to delivering innovative cancer care rooted in evidence-based medicine and a holistic approach. Patients have access to a full spectrum of services for diagnosis, treatment, survivorship, and ongoing support close to home, eliminating the need for long-distance travel.

“We are thrilled to welcome Dr. Juncaj to Low Country Cancer Care,” shared medical oncologist Jennifer Yannucci, MD. “His knowledge and commitment to delivering compassionate, personalized care will enhance our team’s ability to offer patients the very best treatment options. We look forward to collaborating with him.”

“On behalf of AON, I am pleased to welcome Dr. Juncaj to Low Country Cancer Care and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “His impressive training and patient-first philosophy make him an excellent fit for our community practices. I am confident that both patients and colleagues will benefit greatly from his skills and dedication.”

Dr. Juncaj will accept patients at the Statesboro clinic on Mondays and Wednesdays and the Savannah clinic on Tuesdays, Thursdays, and Fridays.

For more information about American Oncology Network, visit AONcology.com. For more information about Low Country Cancer Care, visit lcccsav.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Low Country Cancer Care
Low Country Cancer Care (LCCC) is a specialized practice devoted to the care of people with cancer and blood disorders as well as the prevention and eradication of these types of diseases. LCCC combines patient care, prevention, education, and research to benefit Georgia and South Carolina cancer patients. LCCC provides advanced treatment and world-class medicine in a warm, compassionate, and personalized environment. LCCC’s experienced and highly trained team is dedicated to providing high-quality diagnosis, treatment, and care with a human touch. Learn more at lcccsav.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Genesis Cancer and Blood Institute and American Oncology Network Welcome Dr. Beau Hilton

/in /by

HOT SPRINGS, ARK., Sept. 2, 2025 –  Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON), is pleased to welcome medical oncologist Beau Hilton, MD, to its physician care team. He joins an experienced group of physicians including Drs. Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, Kristen Sager, Brad Baltz, Jim Chen and Tyler Fugere.

Dr. Hilton earned his Doctor of Medicine from the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He completed his internal medicine residency and hematology-oncology fellowship at Vanderbilt University Medical Center.

He is a member of the American Society of Hematology, the American Society of Clinical Oncology and the American College of Physicians. Dr. Hilton is passionate about providing personalized, patient-centered care in the community setting.

“I’m honored to join Genesis Cancer and Blood Institute,” said Dr. Hilton. “The practice has a long-standing reputation for exceptional patient care, and its mission aligns closely with my own values. I look forward to working alongside this dedicated team to provide leading-edge, compassionate treatment for our patients.”

With 11 medical oncologists and five advance practice providers across 11 locations in Arkansas,  Genesis Cancer and Blood Institute offers comprehensive services for cancer diagnosis, treatment, clinical trials, survivorship and patient support—all delivered close to home.

“We are delighted to welcome Dr. Hilton to our practice,” said Dr. Timothy Webb, medical oncologist at Genesis. “His expertise, compassion and dedication to individualized care make him a tremendous addition to our team. I’m confident our patients will benefit greatly from his knowledge and approach to treatment.”

“On behalf of AON, I’m thrilled to welcome Dr. Hilton to Genesis and to our national network,” said Stephen “Fred” Divers, MD, medical oncologist at Genesis and AON’s chief medical officer. “His skill, empathy and commitment to high-quality, community-based care are exactly what we value at AON. He will be an asset to both our team and the patients we serve every day.”

Dr. Hilton began seeing patients at both Genesis Hot Springs clinics on Sept. 1, 2025.

For more information about AON, visit AONcology.com. To learn more about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Genesis Cancer and Blood Institute
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. Brad Baltz, Dr. Jim Chen, Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, Dr. Tyler Fugere, and Dr. Beau Hilton. Learn more at genesiscancerblood.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Reports Strong Growth and Record Milestones in 2025

/in /by

Annual revenue surpasses $2 billion for the 12 months ended June 30, 2025, reflecting >40% growth over the prior 12-month period. Provider network grows to >300 across 20 states. New treatment innovations broaden access to cutting-edge cancer care

FORT MYERS, Fla., Aug. 12, 2025 – American Oncology Network (AON), one of the fastest-growing networks of community-based oncology practices in the United States, today announced the achievement of multiple key milestones. Fueled by new and expanding partnerships, groundbreaking treatment innovations, and a steadfast commitment to patient-centered care, AON continues to advance its mission of delivering world-class oncology care to more communities across the country.

With annual revenue surpassing $2 billion for the 12 months ended June 30, 2025, AON continues to demonstrate strong momentum. This revenue represents >40% growth over the 12 months ended June 30, 2024 and is driven by both organic expansion and the addition of numerous practices and providers in new markets. The network now includes more than 300 oncology and hematology providers across 20 states, offering expanded access to advanced treatments and diagnostics.

Looking ahead, AON is inviting new partners to join its growing national network, where they can preserve clinical autonomy and focus on patients while growing revenue with access to best-in-class support infrastructure including an in-house specialty pharmacy, revenue cycle management, prior authorization, innovative data and technology, and more. AON partner practices average a greater than 30% increase in sustainable income after joining. AON maintains a robust pipeline of practices interested in benefitting from AON’s unique value proposition.

“AON’s growth and momentum reflects the strength of our model and the commitment of our partner practices to transform how cancer care is delivered in communities across the country,” said Todd Schonherz, chief executive officer of AON. “We’re not just growing—we’re delivering measurable improvements in patient access, experience and outcomes.”

2025 YTD Growth and Innovation Highlights

A Vision for the Remainder of 2025

AON is positioned to amplify its national impact by advancing clinical innovation, strengthening partnerships and supporting the long-term sustainability of community oncology. Practices that join AON gain access to a robust suite of services and tools that help them grow while delivering exceptional care.

“We remain committed to ensuring that every patient receives personalized, high-quality care while reducing costs and improving outcomes,” said Dr. Stephen “Fred” Divers, chief medical officer of AON. “We’re proud to welcome new providers who share our vision and dedication to advancing care in the communities where patients live.”

For more information about AON, visit AONcology.com.

Financial Disclosure Advisory

This press release contains certain financial results for the twelve month period ended June 30, 2025. The financial results have not been audited or reviewed by the Company’s independent registered public accounting firm. Accordingly, the Company’s independent registered public accounting firm does not express an opinion with respect thereto, and you should not place undue reliance on such financial results. This press release also contains forward-looking statements, including but not limited to statements regarding anticipated growth, future treatment offerings, physician recruitment, and potential financial outcomes. These statements are based on current expectations and projections and are subject to risks and uncertainties that may cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. AON assumes no obligation to update or revise any such statements unless required by law.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:

Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network and The Center for Cancer and Blood Disorders Welcome Dr. Garrett Diltz and Dr. Shreya Desai

/in /by

Board-certified medical oncologists join AON’s CCBD physician team.

BETHESDA, Md., Aug. 6, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its partner practice, The Center for Cancer and Blood Disorders (CCBD), are pleased to welcome Board-certified medical oncologists Garrett Diltz, MD,  and Shreya Desai, MD, to the care team. Both physicians will serve patients in Bethesda and Germantown, Maryland, alongside the practice’s existing team of experienced providers.

Dr. Diltz earned his medical degree from The Ohio State University College of Medicine, graduating summa cum laude and as a member of the Alpha Omega Alpha Honor Society. He completed his residency at Beth Israel Deaconess Medical Center/Harvard Medical School and his hematology-oncology fellowship at MedStar Georgetown University Hospital, where he was chief fellow.

“My goal is to provide personalized cancer care that supports the whole patient,” said Dr. Diltz. “I am excited to join the physician team at CCBD because they prioritize delivering the highest quality of care while building strong patient relationships, just as I do.”

Dr. Desai earned her medical degree from Ross University School of Medicine and completed her internal medicine residency at Rosalind Franklin University of Medicine and Science. She went on to complete a hematology-oncology fellowship at the Medical College of Georgia, where she served as chief fellow. She is fluent in Gujarati and Hindi.

“I am proud to join the physician team at The Center for Cancer and Blood Disorders and become a part of the American Oncology Network,” said Dr. Desai. “CCBD and AON share my commitment to high-quality, patient-focused care in a community setting, and the organizations’ reputation for excellence and compassion makes this the right fit for me.”

CCBD provides community-based oncology services to patients in Bethesda, Germantown, and Baltimore, Maryland. The practice offers comprehensive cancer care, including diagnostics, cutting edge treatments, clinical trials that offer innovative opportunities, survivorship programs and patient support – all delivered close to home to reduce travel burdens for patients and their families. CCBD clinics feature private exam rooms and on-site infusion suites designed for patient comfort and privacy during treatment.

“We are excited to have Dr. Desai and Dr. Diltz join our practice,” said Ralph Boccia, MD, FACP, Medical Director and managing partner. “Both doctors are dedicated to evidence-based, compassionate care, which aligns perfectly with our values and those of the other providers on our team. We are looking forward to benefiting from their expertise.”

“On behalf of AON, I am delighted to welcome these outstanding physicians to our network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Their experience and patient-centered approach will strengthen the level of care we offer in our Maryland communities and across the network.”

Dr. Desai and Dr. Diltz are now accepting new patients at CCBD’s Bethesda and Germantown locations. For more information about AON, visit AONcology.com. To learn more about The Center for Cancer and Blood Disorders, visit ccbdmd.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers’ innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About The Center for Cancer and Blood Disorders
Specialists in the diagnosis and treatment of blood disorders and cancer, The Center for Cancer and Blood Disorders has been serving patients in the communities and surrounding areas of Bethesda and Germantown, Maryland for more than 25 years. Their individualized approach to patient care includes chemotherapy, targeted therapy, immunotherapy and when appropriate, cutting-edge therapies on clinical trials. The practice regularly performs more than 300 clinical trials on new and developing diagnostic devices and techniques for cancer and diseases. Patients receive home delivery of oral cancer medications, in-house lab and pathology and on-site infusion therapy. The practice also offers comprehensive support with nutrition guidance and financial counseling. Learn more at ccbdmd.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Genesis Cancer and Blood Institute and American Oncology Network Welcome Dr. Tyler Fugere

/in /by

Genesis Cancer and Blood Institute and American Oncology Network Welcome Dr. Tyler Fugere.

HOT SPRINGS, ARK., Aug. 5, 2025 –  Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON), is pleased to welcome Board-certified physician Tyler Fugere, MD, to its physician care team. She joins an experienced group of physicians including Drs. Brad Baltz, Jim Chen, Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, and Kristen Sager.

Dr. Fugere is a Board-certified medical oncologist and hematologist. She earned her medical degree from the University of Arkansas for Medical Sciences (UAMS) in Little Rock, where she also completed her internal medicine residency and hematology-oncology fellowship. Originally from Benton, Arkansas, she graduated summa cum laude from Benton High School and later earned her undergraduate degree from Ouachita Baptist University in Arkadelphia.

She is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the National Comprehensive Cancer Network. Dr. Fugere is passionate about providing personalized, patient-centered care in the community setting.

“I’m honored to join Genesis Cancer and Blood Institute,” said Dr. Fugere. “Genesis has a long-standing reputation for excellence in patient care, and its values align perfectly with my own. I look forward to being part of a team that puts patients first while offering the latest in evidence-based treatment.”

With 10 medical oncologists and five advance practice providers across 11 locations in Arkansas,  Genesis Cancer and Blood Institute offers comprehensive services for cancer diagnosis, treatment, clinical trials, survivorship and patient support—all delivered close to home.

“We’re excited to welcome Dr. Fugere to the Genesis team,” said Dr. Timothy Webb, medical oncologist at Genesis. “Her knowledge, compassion and dedication to personalized care make her a perfect addition to our group. I know our patients will benefit from her expertise.”

“On behalf of AON, I’m pleased to welcome Dr. Fugere to Genesis and to our national network,” said Stephen “Fred” Divers, MD, medical oncologist at Genesis and AON’s chief medical officer. “Her commitment to delivering high-quality, community-based care reflects AON’s mission to make exceptional cancer treatment accessible to patients where they live. She will be an invaluable asset to both our team and the patients we serve.”

Dr. Fugure began seeing patients at the Genesis Benton and Little Rock clinics on Aug. 1, 2025.

For more information about AON, visit AONcology.com. To learn more about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Genesis Cancer and Blood Institute
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. Brad Baltz, Dr. Jim Chen, Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, and Dr. Tyler Fugere. Learn more at genesiscancerblood.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Expands Arkansas Presence, Adds Conway Hematology Oncology to National Network

/in /by

CONWAY, Ark., Aug. 5, 2025– Conway Hematology Oncology (CHO), a trusted provider of hematology and oncology care in Conway, Arkansas, is proud to announce it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices.

This partnership enables CHO to expand patient-focused services, grow clinical trial offerings, and pursue new market opportunities—while continuing to provide the high-quality, compassionate care that has defined the practice for more than 25 years.

Dr. Sue Tsuda, a Board-certified medical oncologist and hematologist, co-founded Conway Hematology Oncology in 1998 and has cared for patients in the Conway area ever since. She earned her medical degree from Northwestern University and completed her residency at Evanston Hospital. Dr. Tsuda completed fellowships in hematology at Rush-Presbyterian-St. Luke’s Medical Center, blood banking at Barnes Hospital, and medical oncology at Washington University in St. Louis. She has conducted research at Washington University and previously served as an assistant professor at the University of Arkansas for Medical Sciences. Dr. Tsuda is a member of the American Society of Clinical Oncology and the Southern Association of Oncology and has been recognized on The Best Doctors in America list annually since 1996.

Christine Lightfoot, a Board-certified nurse practitioner, earned both her Bachelor and Master of Science in nursing with a concentration in family nurse practice from the University of Central Arkansas in Conway. She has been caring for patients in Arkansas since 2010.

Courtney Nash,  a Board-certified nurse practitioner, earned her Master of Science in nursing from the University of Central Arkansas in Conway and her Bachelor of Science in nursing from the University of Arkansas in Fayetteville. She has been providing care in Arkansas since 2006.

“We’re proud to join American Oncology Network,” said Dr. Tsuda. “AON’s commitment to personalized, high-quality care delivered in a community setting mirrors the mission we’ve upheld for decades. This partnership enables us to broaden our services and bring advanced treatments to our patients, while continuing to provide the compassionate care they’ve come to expect.”

Conway Hematology Oncology offers comprehensive community-based oncology services to patients in Conway and surrounding areas, including the latest diagnostic and treatment technologies, private exam rooms, an onsite laboratory, and infusion suites designed for comfort and privacy.

“We are thrilled to welcome Conway Hematology Oncology to the American Oncology Network,” said  Todd Schonherz, AON’s chief executive officer. “CHO is well known for its outstanding patient-centered care, and their clinical expertise is a perfect fit with AON’s mission to make high-quality, individualized cancer treatment accessible in local communities.”

“On behalf of AON, I’m excited to welcome the CHO team to our network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Their dedication to delivering excellent care in a community setting has made a lasting difference in Conway. Their experience and values will strengthen our collective efforts to improve community cancer care across the country.”

Dr. Tsuda, Christine Lightfoot, and Courtney Nash are now accepting new patients. For more information about AON, visit AONcology.com. To learn more about Conway Hematology Oncology, visit conwayhematologyoncology.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Conway Hematology Oncology
Conway Hematology Oncology (CHO) has been a trusted name in Conway, Arkansas cancer care since 1998. In August 2025, the practice joined American Oncology Network (AON). Conway Hematology Oncology is the longest running full-time cancer clinic in Faulkner County, Arkansas. The practice understands the profound effects cancer can have on a person and is dedicated to the physical and mental health of cancer patients and their families, working hard to provide patients with the best cancer treatment in an atmosphere of caring encouragement. Conway offices are equipped with the latest diagnostic and treatment technologies including an onsite laboratory, CT scanning and chemotherapy administration. Learn more at conwayhematologyoncology.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Central Lab Receives Reaccreditation from College of American Pathologists

/in /by

FORT MYERS, Fla., July 23, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, has received reaccreditation from

the Accreditation Committee of the College of American Pathologists (CAP) for its Central Laboratory in Fort Myers, Florida. The recognition follows a recent on-site inspection conducted as part of the CAP’s Accreditation Programs.

Recognized for its rigorous standards and commitment to quality, CAP accreditation helps ensure laboratories operate at the highest levels of accuracy and reliability—contributing to improved patient outcomes and reduced clinical risk.

“We are pleased to receive reaccreditation from the College of American Pathologists (CAP) for our central laboratory in Fort Myers,” said Dr. Ryan Olson, medical director of pathology. “The AON central laboratory serves community oncology practices across the country, aiding thousands of patients in receiving timely and accurate results to support better treatment decisions. This reaccreditation reflects our team’s dedication to upholding the highest quality standards.”

Dr. Ryan Olsen, American Oncology Network

“Laboratory medicine plays a critical role in modern cancer care,” said Todd Schonherz, chief executive officer of AON. “CAP reaccreditation reflects the high standards we set for patient care across the entire network. I’m proud of our central lab team for maintaining this elite level of quality and helping ensure our community oncology practices have the tools they need to deliver precise, timely care.”

As part of the accreditation process, CAP inspectors review a laboratory’s records, quality control procedures, staff qualifications, equipment facilities, safety practices and overall management. The program is designed to ensure that laboratories meet or exceed the industry’s most current standards and best practices.

 In addition to accreditation, the College of American Pathologists supports more than 23,000 laboratories through proficiency testing, quality improvement tools, and best-in-class protocols and guidelines. Built on a foundation of pathologist expertise, the CAP partners with laboratories around the world to drive operational excellence, improve diagnostic confidence and ensure high-quality patient care.

###

About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit the CAP Newsroom, CAP.org and yourpathologist.org to watch pathologists at work and see the stories of the patients who trust them with their care.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

More Than 40 American Oncology Network Clinics Across 18 States and Washington, D.C., Now Offering Bispecific T-cell Engager Therapies to Patients

/in /by

AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard-to-treat cancers

FORT MYERS, Fla., July 21, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, is now offering Bispecific T-cell Engager (BiTE) therapy—also known as BiTE therapy—at more than 40 partner practice clinics in 18 states and Washington, D.C. This advancement brings cutting-edge cancer treatment directly to patients in community settings, expanding access to a promising class of immunotherapies that may offer new hope for those with cancers resistant to standard treatments.

Bispecific therapies represent a major breakthrough in cancer care. These innovative therapies engage a patient’s own immune system by targeting two different molecules—one on a cancer cell and one on a T cell (a type of immune cell). By binding to both simultaneously, bispecific antibodies act as a bridge, directing the T cell to the tumor and triggering the immune system to attack the cancer directly.

“At AON, we’re committed to staying at the forefront of cancer care by integrating innovative therapies like bispecific antibodies into our clinical offerings,” said Melody Chang, RPh, MBA, BCOP, vice president of pharmacy operations at AON. “These therapies are an important part of our personalized treatment approach and have already shown promise in improving outcomes for patients with some of the most challenging cancers.”

Since March 2025, AON has provided bispecific antibody therapy to patients with acute lymphoblastic leukemia, uveal melanoma, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma and extensive-stage small cell lung cancer.

“Bispecific therapies are particularly important for patients whose cancers no longer respond to traditional treatments,” said Dr. Stephen “Fred” Divers, chief medical officer at AON. “By expanding access to these therapies in the community setting, AON is helping patients stay close to home while receiving some of the most advanced treatment options available.”

AON’s implementation of BiTE therapies ensures patients across its national network can benefit from these innovations without the need to travel to academic medical centers or major research institutions.

How Bispecific Therapies Work:

  • Dual Targeting: Bispecific antibodies are engineered to recognize two targets—typically a cancer cell marker and a T cell receptor.
  • T Cell Engagement: The therapy draws T cells to the cancer site, increasing immune activity at the tumor.
  • Targeted Immune Activation: This precise approach enhances the immune response, improving the likelihood of destroying cancer cells while minimizing harm to healthy tissue.

In addition to offering these therapies, AON actively participates in clinical trials and collaborates with leading researchers to explore new applications of bispecific antibodies in oncology.

“AON’s expansion of bispecific antibody therapies reflects our mission to bring the most advanced treatments to local communities,” said Todd Schonherz, chief executive officer at AON. “Our focus on innovation and access allows patients to receive world-class care from trusted local providers without having to leave their support systems behind.”

To learn more about how bispecific therapies work, visit: https://www.aoncology.com/education-posts/understanding-bispecific-therapies-bite/

AON partner practices offering bispecific therapies include:

(**Practices Offering Complete Outpatient Services)

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Florida Oncology and Hematology Expands Fort Myers Clinic, Adds PET Services

/in /by

Local oncology practice enhances state-of-the-art location to include radiology services that improve cancer care for the Lee County community.

FORT MYERS, FL, July 15, 2025 – Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has expanded its Fort Myers clinic at 14551 Hope Center Loop to include radiology services. Current and prospective patients can call (239) 264-7026 for more information or to schedule an appointment.

Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now seeing patients at the new location.

The expanded clinic offers PET services, 12 exam rooms for patient consultations, nearly 30 infusion chairs and an on-site lab.

“Our Fort Myers practice now includes radiology services, allowing us to better meet the needs of our patients throughout Lee County,” said medical director, Dr. Van den Bergh. “Delivering compassionate, high-quality care remains our top priority. This expansion enables us to provide that care in a more comprehensive and comfortable setting. We’re grateful for the trust our patients place in us and look forward to welcoming them to the expanded space.”

Florida Oncology and Hematology operates five clinics serving patients in Cape Coral, Clearwater, Fort Myers, Naples and surrounding areas. The practice is dedicated to providing personalized care plans tailored to each patient’s unique needs. As a community-based oncology group, it offers high-quality, affordable care in a supportive and accessible environment.

The practice is a partner of American Oncology Network, one of the fastest-growing community oncology networks in the United States. Through this partnership, patients have access to expanded services such as an in-house specialty pharmacy, which provides home delivery of select medications, along with other supportive care resources.

“We’re proud to continue growing alongside our community,” said Dr. Parsa. “The addition of PET services not only allows us to provide diagnostic PET and CT imaging, but it also provides the technology to offer innovative Radioligand Therapy to treat a variety of cancers such as prostate and neuroendocrine tumors in a more direct and targeted way. Now, we’re able to deliver additional services for our patients—all in one convenient location.”

For more information about AON, visit AONcology.com. To learn more about Florida Oncology and Hematology, visit floridaonc.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Florida Oncology and Hematology
Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Cape Coral, Clearwater, Fort Myers, and Naples, Florida. As a community-based practice, it offers a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at floridaonc.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com